The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosisP. D. Molyneux, D. H. Miller, Tarek Yousry et al.|Brain|2000Cited by 241
Guidelines for using quantitative measures of brain magnetic resonance imaging abnormalities in monitoring the treatment of multiple sclerosisMassimo Filippi, D. H. Miller, Mark A. Horsfield et al.|Annals of Neurology|1998Cited by 171
Sample sizes for brain atrophy outcomes in trials for secondary progressive multiple sclerosisDaniel R. Altmann, D. H. Miller, Bas Jasperse et al.|Neurology|2008Cited by 100